Latest News from: University of Miami Health System, Miller School of Medicine

Filters close
Released: 20-Feb-2024 8:00 AM EST
Sylvester Comprehensive Cancer Center Tip Sheet for Feb. 2024
Sylvester Comprehensive Cancer Center

A guitarist begins 2024 on high note after awake brain surgery, Dr. Damian Green named chief of Transplantation & Cellular Therapy, targeting treatment resistance in CLL, expanding the patient pool for immunotherapy, researching potential new treatments for head and neck cancer, and more are included in this month’s tip sheet.

Newswise: Sylvester Appoints Prominent Oncologist-Researcher to Lead Transplantation and Cellular Therapy
Released: 16-Feb-2024 12:05 PM EST
Sylvester Appoints Prominent Oncologist-Researcher to Lead Transplantation and Cellular Therapy
Sylvester Comprehensive Cancer Center

Prominent oncologist and researcher Damian Green, M.D., is joining Sylvester Comprehensive Cancer Center as chief of the Division of Transplantation & Cellular Therapy. A specialist in multiple myeloma and other B-cell malignancies, his research has led to the discovery and testing of several pioneering immunotherapy approaches to treat myeloma and other blood cancers.

Newswise: Cancer Prevention Programs Coming to Communities Across Florida
Released: 6-Feb-2024 9:00 AM EST
Cancer Prevention Programs Coming to Communities Across Florida
Sylvester Comprehensive Cancer Center

Three leading Florida academic cancer centers – Sylvester Comprehensive Cancer Center at the University of Miami Health System, Moffitt Cancer Center and the University of Florida Health Cancer Center – have joined to fund thousands of dollars for four projects statewide to help people detect and treat cancer early.

Newswise: Targeting Treatment Resistance in Chronic Lymphocytic Leukemia
28-Jan-2024 8:00 PM EST
Targeting Treatment Resistance in Chronic Lymphocytic Leukemia
Sylvester Comprehensive Cancer Center

New research has identified a next-generation BTK degrader that could help overcome treatment resistance in CLL and related blood cancers.

Newswise: Urology on the Beach Meeting Highlights Innovative Approaches to Multidisciplinary Care
Released: 26-Jan-2024 1:05 PM EST
Urology on the Beach Meeting Highlights Innovative Approaches to Multidisciplinary Care
University of Miami Health System, Miller School of Medicine

Renowned urologists from leading academic centers shared their insights and clinical recommendations at Urology on the Beach, a three-day professional conference hosted by the Desai Sethi Urology Institute (DSUI) at the University of Miami Miller School of Medicine.

Newswise: New National Survey by Desai Sethi Urology Institute Reveals Impact of Technology & Multidisciplinary Collaboration on the Future of Urology
Released: 23-Jan-2024 1:05 PM EST
New National Survey by Desai Sethi Urology Institute Reveals Impact of Technology & Multidisciplinary Collaboration on the Future of Urology
University of Miami Health System, Miller School of Medicine

The Desai Sethi Institute of Urology (DSUI) at the University of Miami Miller School of Medicine unveiled the findings of its inaugural State of Urology survey and report today, which provides insights into the current landscape of urology and outlines implications for the future direction of the specialty.

   
Newswise: Research Shows Deadly Brain Cancer Can Mimic Healthy Neurons
8-Jan-2024 10:05 PM EST
Research Shows Deadly Brain Cancer Can Mimic Healthy Neurons
Sylvester Comprehensive Cancer Center

Glioblastoma, an incurable brain cancer, is characterized by cells that can mimic human neurons, even growing axons and making active connections with healthy brain neurons.

Newswise: Personalizing Lifestyle Interventions for Cancer Survivors
Released: 10-Jan-2024 5:05 PM EST
Personalizing Lifestyle Interventions for Cancer Survivors
Sylvester Comprehensive Cancer Center

Researchers with Sylvester Comprehensive Cancer Center have received funding to better understand how personalized nutrition and exercise programs can improve quality of life after cancer treatment.

Newswise: Sylvester-led research group unveils the first individual risk prediction model for multiple myeloma
5-Jan-2024 7:05 PM EST
Sylvester-led research group unveils the first individual risk prediction model for multiple myeloma
Sylvester Comprehensive Cancer Center

A multicenter collaboration led by researchers at Sylvester Comprehensive Cancer Center has produced the first computational model for newly diagnosed multiple myeloma that predicts an individual’s personalized prognosis based on their tumor genomics and treatments.

Newswise: Out with the old and in with a hopeful new year for patient who played guitar during ‘awake’ brain tumor surgery
Released: 8-Jan-2024 1:05 PM EST
Out with the old and in with a hopeful new year for patient who played guitar during ‘awake’ brain tumor surgery
Sylvester Comprehensive Cancer Center

Christian Nolen usually plays guitar on stage, but the professional guitarist recently underwent an open craniotomy and played notes from Deftones songs while a neurosurgical team worked to remove a tumor (glioma) from his brain. B-roll is available.

   
Newswise: Minimizing Immunotherapy’s Potentially Harmful Side Effects
2-Jan-2024 1:05 PM EST
Minimizing Immunotherapy’s Potentially Harmful Side Effects
Sylvester Comprehensive Cancer Center

New research from Sylvester Comprehensive Cancer Center indicates that providing prophylactic treatment before immunotherapy can significantly reduce the rate of cytokine release syndrome (CRS) in multiple myeloma patients. Study appears Jan. 4, 2024, in Blood Cancer Discovery.

Released: 20-Dec-2023 3:05 PM EST
December Tip Sheet from Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center

How interactions between tumor genes, microenvironment affect multiple myeloma treatment responses, a new AI technique could guide glioblastoma treatment, new research shows birth country a key risk factor in stomach cancer, how petrochemicals fuel cancer risk and more are included in this month’s tip sheet.

Newswise: Sylvester cancer researcher and technology innovator named fellow of the National Academy of Inventors
Released: 18-Dec-2023 4:05 PM EST
Sylvester cancer researcher and technology innovator named fellow of the National Academy of Inventors
Sylvester Comprehensive Cancer Center

Shanta Dhar, Ph.D., assistant director of Technology and Innovation at Sylvester Comprehensive Cancer Center, has been named a fellow of the National Academy of Inventors. Her inventions and innovative contributions in nanomedicine, mitochondria-targeted drug delivery, and platinum-based prodrugs help guide targeted therapies in cancer and other diseases.

29-Nov-2023 7:05 PM EST
ASH 2023 Tip Sheet From Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center

Physician-scientists and other researchers from Sylvester Comprehensive Cancer Center will make presentations at the American Society of Hematology’s 2023 annual meeting Dec. 9-12. This tip sheet highlights several of those presentations.

Newswise: Combination immunotherapy produces high response rate in early results of Sylvester trial targeting high-risk follicular lymphoma
4-Dec-2023 8:30 PM EST
Combination immunotherapy produces high response rate in early results of Sylvester trial targeting high-risk follicular lymphoma
Sylvester Comprehensive Cancer Center

Researchers conducting a Phase 2 clinical trial at Sylvester Comprehensive Cancer Center say a new combination of antibody therapies produced a ‘surprisingly high’ response rate in patients with high-risk follicular lymphoma, a type of non-Hodgkin lymphoma.

Newswise: Multicenter Study at Sylvester, Other Academic Centers Shows CAR-T Cell Therapy Safe, Effective Even for High-Risk Patients
4-Dec-2023 7:05 PM EST
Multicenter Study at Sylvester, Other Academic Centers Shows CAR-T Cell Therapy Safe, Effective Even for High-Risk Patients
Sylvester Comprehensive Cancer Center

CAR-T cell therapy is a safe and effective treatment for diffuse large B-cell lymphoma (DLBCL), even for patients regarded as high risk due to comorbidities. That’s the conclusion of a five-year analysis of results from the U.S. Lymphoma CAR-T Cell Consortium.

Newswise: Patients with a common form of acute myeloid leukemia report better quality of life when treatment includes new drug quizartinib
4-Dec-2023 8:05 PM EST
Patients with a common form of acute myeloid leukemia report better quality of life when treatment includes new drug quizartinib
Sylvester Comprehensive Cancer Center

In a study led by researchers at Sylvester Comprehensive Cancer Center, patients recently diagnosed with a common and aggressive form of acute myeloid leukemia reported having improved quality of life when a newly approved drug was part of the treatment plan.

Newswise: Research By Sylvester, Collaborators Leads to New Treatment Options for Advanced Myelofibrosis, Other Blood Malignancies
5-Dec-2023 11:05 AM EST
Research By Sylvester, Collaborators Leads to New Treatment Options for Advanced Myelofibrosis, Other Blood Malignancies
Sylvester Comprehensive Cancer Center

New research conducted by investigators at Sylvester Comprehensive Cancer Center and collaborating cancer centers indicates that a new type of targeted therapy may offer new treatment options for patients living with advanced myelofibrosis, a bone marrow disorder. Study results will be shared at ASH 2023 in San Diego, Dec. 9-12.

Newswise: Cell Therapy Appears Safe and Effective for Lymphoma in Remission
5-Dec-2023 9:05 PM EST
Cell Therapy Appears Safe and Effective for Lymphoma in Remission
Sylvester Comprehensive Cancer Center

A study led by researchers at Sylvester Comprehensive Cancer Center suggests that CAR-T immunotherapy remains a viable option for patients who have lymphoma that goes into remission before the cell therapy begins. Downloadable video is available.

Newswise: Landscape for AML Patients Evolving Rapidly as Research Discoveries Advance New Treatments
4-Dec-2023 10:05 PM EST
Landscape for AML Patients Evolving Rapidly as Research Discoveries Advance New Treatments
Sylvester Comprehensive Cancer Center

The treatment landscape for acute myeloid leukemia (AML) is evolving rapidly, as research discoveries at Sylvester Comprehensive Cancer Center and other academic cancer centers advance new, more effective therapies for this aggressive blood cancer.

5-Dec-2023 12:45 PM EST
ASH Research Alert: New Sylvester Cancer Study Provides Insight Into Underlying Gene Mutations in Myelodysplastic Syndromes
Sylvester Comprehensive Cancer Center

A new study from researchers with Sylvester Comprehensive Cancer Center and collaborating organizations provides insight into the underlying mechanisms of gene mutations commonly seen in patients with myelodysplastic syndromes (MDS) and other myeloid neoplasms.

Not for public release

This news release is embargoed until 1-Dec-2023 5:05 AM EST Released to reporters: 24-Nov-2023 10:05 AM EST

A reporter's PressPass is required to access this story until the embargo expires on 1-Dec-2023 5:05 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Desai Sethi Urology Institute Performs First Prepubertal Male Fertility Preservation
Released: 30-Nov-2023 1:05 PM EST
Desai Sethi Urology Institute Performs First Prepubertal Male Fertility Preservation
University of Miami Health System, Miller School of Medicine

The investigational procedure, done in collaboration with University of Pittsburgh Medical Center (UPMC), harvests testicular tissue containing stem cells in prepubertal boys who are about to undergo treatments for cancer or other conditions that might result in infertility.

Newswise: ‘Safari & Science’ Art Exhibit Merges Art with Science during Art Basel
Released: 29-Nov-2023 8:00 AM EST
‘Safari & Science’ Art Exhibit Merges Art with Science during Art Basel
Sylvester Comprehensive Cancer Center

The 'Safari and Science,' art exhibit at Sylvester Comprehensive Cancer Center opens Dec. 1. The exhibit blends photographs of Africa with the scientific research Sophia George, Ph.D., is conducting worldwide to control and prevent cancer in the Black community.

Newswise: Sylvester study: Country of birth a key factor in assessing risk for conditions favorable to stomach cancer development
Released: 28-Nov-2023 12:05 PM EST
Sylvester study: Country of birth a key factor in assessing risk for conditions favorable to stomach cancer development
Sylvester Comprehensive Cancer Center

Researchers at Sylvester Comprehensive Cancer Center have found that country of birth – not just geographic region – is a key risk factor for gastric intestinal metaplasia, a precursor lesion of stomach cancer.

Newswise: New AI Technique Could Guide Real-time Glioblastoma Treatment
Released: 13-Nov-2023 3:05 PM EST
New AI Technique Could Guide Real-time Glioblastoma Treatment
Sylvester Comprehensive Cancer Center

A new AI technique could guide real-time GBM treatment. Researchers are using MRI-guided radiation therapy that pairs daily MRIs with radiation treatment -- automatically tracing tumors in large MRI datasets.

8-Nov-2023 4:05 PM EST
Sylvester research shows how interactions between tumor genes and microenvironment influence treatment response in multiple myeloma
Sylvester Comprehensive Cancer Center

A multicenter study led by researchers at Sylvester Comprehensive Cancer Center shows how interactions between tumor cells and immune components of the microenvironment can impact treatment responses and outcomes in patients newly diagnosed with multiple myeloma who undergo combination treatments that include targeted immunotherapy.

Newswise: Pioneering Sylvester Physician Elected to Society of Neuro-Oncology Board
Released: 7-Nov-2023 3:05 PM EST
Pioneering Sylvester Physician Elected to Society of Neuro-Oncology Board
Sylvester Comprehensive Cancer Center

Macarena de la Fuente, MD, chief of neuro-oncology at Sylvester Comprehensive Cancer Center, has been elected to the Society of Neuro-Oncology (SNO)’s board of directors. She becomes the first Hispanic elected to the multidisciplinary board.



close
0.47907